Clinical Trial Update: Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing concurrent chemoradiotherapy with nedaplatin versus cisplatin for nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: COMPLETED